Washington Trust Bank’s Juno Therapeutics, Inc. JUNO Stock Holding History

Washington Trust Bank’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11	Closed	–	–	1064
2016 Q4	$0	Hold	11	–	–	﹤0.01%	1153
2016 Q3	$0	Buy	+11	New	+$342	﹤0.01%	1223
2016 Q1	–	Sell	-200	Closed	-$9K	–	839
2015 Q4	$9K	Buy	+200	New	+$9.92K	﹤0.01%	616

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Washington Trust Bank's JUNO Position: Q1 2017 in Review

Washington Trust Bank sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2017, closing a stake of 11 shares.

Washington Trust Bank first reported a position in JUNO in Q4 2015 and held it in 3 quarters. The position peaked at $9K in Q4 2015. 157 funds tracked by Wall St. Rank hold JUNO as of Q1 2017.

Washington Trust Bank reported no remaining Juno Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Washington Trust Bank sold 11 Juno Therapeutics, Inc. shares in Q1 2017.
Washington Trust Bank first reported a position in Juno Therapeutics, Inc. in Q4 2015 and held it in 3 quarters.
Washington Trust Bank's Juno Therapeutics, Inc. position peaked at $9K in Q4 2015.
157 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2017.

Based on Washington Trust Bank's 13F filing for Q1 2017, filed 18 Apr 2017.